BLACKROCK NEUROTECH
Blackrock Neurotech, formerly known as Blackrock Microsystems, is dedicated to the clinical translation of brain-computer interface (BCI) technology.
blackrockneurotech.com/
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation for its groundbreaking MoveAgain Brain Computer Interface (BCI) System. (Nov 2021)
blackrockneurotech.com/insig…
The co-founder of Palantir Technologies Inc Peter Thiel announces he is investing $10M in Blackrock Neurotech during funding round. (2021)
siliconangle.com/2021/05/19/…
Blackrock Neurotech LLC has acquired spatial computing software startup Mindx Corp. to advance full-stack brain-computer interface (BCI) products. As part of the transaction, Mindx’s augmented reality (AR) and artificial intelligence (AI) technology will be integrated with Blackrock’s BCI hardware. (2022)
bioworld.com/articles/518203…
Blackrock Neurotech, the leader in brain-computer interface (BCI) technology, has announced a record-breaking milestone–30,000 days of in-patient BCI research, roughly 20 times longer than any other implantable BCI technology reported to date. (2022)
prnewswire.com/news-releases…
Cryptocurrency company Tether announced an investment of $200 million into Blackrock Neurotech to take a majority stake in the Brain Computer Interface (BCI) company (April 2024)
tether.io/news/tether-takes-…
May 2019, Battelle wins contract to inject US soldiers with Bidirectional N3 Neural Swarm, BCI technology.
Part of DARPA’s TELLUS goal, using Friedman’s, Lieber’s, Kruse’s, Giordano’s, Akyildiz’s, & many other’s, for Tracking, DNA Data, Crypto, & Energy Harvesting, To Control Us.